Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Impact of CD200-Fc on dendritic cells in lupus-prone NZB/WF1 mice

Journal Article · · Scientific Reports
DOI:https://doi.org/10.1038/srep31874· OSTI ID:1326665
 [1];  [2];  [2];  [2]
  1. Peking Union Medical College Hospital, Beijing (China). Key Lab. of Rheumatology & Clinical Immunology, Dept. of Rheumatology & Clinical Immunology; Chinese Academy of Medical Science (CAS), Beijing (China). Clinical Immunology Center; none
  2. Peking Union Medical College Hospital, Beijing (China). Key Lab. of Rheumatology & Clinical Immunology, Dept. of Rheumatology & Clinical Immunology; Chinese Academy of Medical Science (CAS), Beijing (China). Clinical Immunology Center
Abnormal expression of CD200/CD200R1 may contribute to the immunologic abnormalities in patients with systemic lupus erythematosus (SLE). This study aimed to assess the function of CD200/CD200R1and impact of CD200-Fc on dendritic cells in lupus-prone NZB/WF1 mice. Female NZB/WF1 mice were treated with CD200-Fc or control for 4 weeks. Plasma samples were collected to measure autoantibody levels. The expression levels of CD200/CD200R1 in peripheral blood mononuclear cells (PBMCs) and splenocytes were examined. The percentage of CD200/CD200R1-positive cells in splenocytes from NZB/WF1 mice was lower than that of C57BL/6 mice (p<0.05). The plasma level of anti-dsDNA was significantly higher in NZB/WF1 mice than C57BL/6 mice (p<0.001). However, the anti-dsDNA levels decreased (p=0.047) after CD200-Fc treatment. Finally, CD200-Fc reduced the levels of IL-6 (p=0.017) and IL-10 (p=0.03) in the dendritic cell culture supernatant. This study suggests that the immunosuppressive CD200/CD200R1 signaling pathway might be involved in the immunopathology of NZB/WF1 mice; the present results merit further exploration of agents that can modulate the CD200/CD200FR1 pathway as a therapy for human lupus.
Research Organization:
Washington Univ., St. Louis, MO (United States)
Sponsoring Organization:
Beijing Municipal Natural Science Foundation; National Natural Science Foundation of China; USDOE
Grant/Contract Number:
SC0001035
OSTI ID:
1326665
Journal Information:
Scientific Reports, Journal Name: Scientific Reports Vol. 6; ISSN 2045-2322
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (26)

CD200-FC, a novel antiarthritic biologic agent that targets proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis journal March 2008
Tolerogenic dendritic cells as a therapy for treating lupus journal August 2013
Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients journal October 2004
Lymphoid/Neuronal Cell Surface OX2 Glycoprotein Recognizes a Novel Receptor on Macrophages Implicated in the Control of Their Function journal August 2000
Dendritic cells and the control of immunity journal March 1998
Mouse and human dendritic cell subtypes journal March 2002
Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. journal January 1994
Localisation of the MRC OX-2 Glycoprotein on the Surfaces of Neurones journal October 1984
Toll Pathway-Dependent Blockade of CD4+CD25+ T Cell-Mediated Suppression by Dendritic Cells journal January 2003
Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200) journal December 2000
Dok2 mediates the CD200Fc attenuation of Aβ-induced changes in glia journal May 2012
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells journal October 2008
An Immunoadhesin Incorporating the Molecule OX-2 Is a Potent Immunosuppressant That Prolongs Allo- and Xenograft Survival journal August 1999
TLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease journal November 2006
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis: ANTI-IL-6 mAb SIRUKUMAB IN ACTIVE LUPUS NEPHRITIS journal August 2016
Lymphoid/Neuronal Cell Surface OX2 Glycoprotein Recognizes a Novel Receptor on Macrophages Implicated in the Control of Their Function journal August 2000
Constitutive Retinal CD200 Expression Regulates Resident Microglia and Activation State of Inflammatory Cells during Experimental Autoimmune Uveoretinitis journal November 2002
Systemic lupus erythematosus and lupus nephritis journal February 2014
Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity journal February 2009
The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF1 mice journal January 2005
Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis journal January 2013
The role of dendritic cells in the pathogenesis of systemic lupus erythematosus journal January 2010
Aberrant CD200/CD200R1 expression and function in systemic lupus erythematosus contributes to abnormal T-cell responsiveness and dendritic cell activity journal January 2012
Retinoic Acid Reduces Autoimmune Renal Injury and Increases Survival in NZB/W F 1 Mice journal June 2003
Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200 journal September 2003
The CD200 Receptor Is a Novel and Potent Regulator of Murine and Human Mast Cell Function journal January 2005

Cited By (1)

The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus journal October 2019

Similar Records

FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice
Journal Article · Fri Apr 09 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22202470

Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype
Journal Article · Thu Mar 31 23:00:00 EST 1988 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:7009395

CpG DNA: A pathogenic factor in systemic lupus erythematosus?
Journal Article · Tue Oct 31 23:00:00 EST 1995 · Journal of Clinical Immunology · OSTI ID:182167